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Peri-implantitis represents amajor complication that can compromise the success and survival of implant-supported rehabilitations.
Both surgical and nonsurgical treatment protocols were proposed to improve clinical parameters and to treat implants affected by
peri-implantitis. A systematic review of the literature was performed on electronic databases. The use of air-polishing powder in
surgical treatment of peri-implantitis was investigated. A total of five articles, of different study designs, were included in the review.
A meta-analysis could not be performed. The data from included studies reported a substantial benefit of the use of air-polishing
powders for the decontamination of implant surface in surgical protocols. A case report of guided bone regeneration in sites with
implants affected by peri-implantitis was presented. Surgical treatment of peri-implantitis, though demanding and not supported
by a wide scientific literature, could be considered a viable treatment option if an adequate decontamination of infected surfaces
could be obtained.
1. Introduction
Dental implants could nowadays be considered a viable
treatment option for total or partial edentulism and their use
is well supported by the scientific literature [1–3].
Long-term success and survival of implant-supported
restorations depend on a number of factors related both to the
subjects and to the characteristics of the implant-prosthesis
structure [4–7].
Biological and technical complications may occur after
implant treatment either immediately after implant or pros-
thesis placement or after years of prosthetic loading.
Technical complications might not affect the success
of the restoration because they can be treated successfully
in almost all cases without causing the loss of implant
osseointegration [8–10].
Short-term biological complications are usually related
to acute infection occurring immediately after surgical inter-
vention or during the healing phase and could cause amassive
bone loss, jeopardizing the osseointegration process [11].
Long-term biological complications are related to the
inflammatory status of peri-implant tissues. Peri-implant
mucositis is a reversible infectious disease characterized by
an inflammatory reaction of peri-implant soft tissues with
swelling and bleeding on probing but without any relevant
bone resorption [12]. If not adequately treated, peri-implant
disease can evolve in peri-implantitis that is characterized by
bone resorption induced by microbial infection that can lead
to the loss of osseointegration [12].
The epidemiology of peri-implant diseases reflects the
spreading of implant treatment that occurred over the years.
The incidence of peri-implant mucositis ranged from 50% to
90%of implants after 8–10 years [13, 14] while peri-implantitis
has been described to affect up to 36.6% of implants [15].
A recent systematic review of the literature confirmed these
results, reporting long-term data [16].
Since peri-implant mucositis can be treated successfully
removing dental plaque from implant and prosthetic com-
ponents, with or without the adjunctive aid of antimicrobial
agents [17–19], peri-implantitis requires more sophisticated
treatment plans.
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Nonsurgical treatments applied to peri-implantitis
involving the use of Er:YAG laser, chlorhexidine [20, 21], and
other devices [22] showing that such treatments can improve
clinical parameters without arresting the progression of
peri-implantitis. Adding local or systemic administration of
antibiotics is possible to obtain bleeding and probing depth
reduction, failing in resolving inflammatory lesions in cases
of bone loss [23, 24].
Surgical treatment of peri-implantitis aims at arresting
the progression of the pathology either filling the bone
defect created by the peri-implant infection or eliminating
the peri-implant pocket through resective procedures [25].
The decontamination of implant surface before guided bone
regeneration (GBR) procedures has to be considered funda-
mental for achieving a successful integration of the grafting
material [25, 26].
The aim of the present paper was to systematically review
the existing literature about the use of air-polishing devices
and powder for the treatment of peri-implantitis. Moreover a
case report was presented.
2. Literature Review
2.1. Materials and Methods. The search of the literature
was performed interrogating electronic databases (Embase,
Medline through PubMed interface, and the entire Cochrane
Library) using an ad hoc prepared search string including
the keywords “air polishing,” “air abrasive,” “glycine,” “peri-
implant disease,” and “peri-implantitis” combined with the
use of Boolean operators “AND” and “OR.” Relevant articles
were also manually selected through the investigation of the
reference lists of the included papers.
Inclusion criteria for the studies were (1) studies concern-
ing the use of air-abrasive powder devices for the treatment
of implant surfaces in the presence of peri-implantitis; (2)
studies describing surgical treatments; (3) any study design.
Two authors (Stefano Corbella and Silvio Taschieri)
independently screened abstracts and full texts of the eligible
papers for possible inclusion. In case of disagreement in the
decision, this was resolved by discussion.
A previously designed electronic sheet served for data
recording after extraction.
The primary outcomes that were evaluated were (1)
implant survival; (2) changes in clinical parameters as peri-
implant probing depth, bleeding, and plaque indexes; (3)
percentage of bone fill of the defect for studies about surgical
treatment of peri-implantitis.
The secondary outcomes were (1) parameters investigat-
ing patients’ quality of life or appreciation of the treatment
and (2) implant success rate.
Data extracted from comparative studieswere included in
the meta-analysis that was performed using ReviewManager
5.1 (Cochrane Library, http://ims.cochrane.org/revman). The
use of air-powder devices was compared to controls. The
meta-analysis was carried out using inverse variance method
and random effects comparing weighted mean difference.
When data could not be included in a meta-analysis a
narrative description was provided.
3. Results
The initial research retrieved a total of 127 titles. After title
and abstract screening, 13 articles were selected for full-texts
examination. Finally, five articles were included in the review
[27–31].
Three articles reported results from prospective studies
[27–29], one was from a retrospective study [31], and one was
a case series [30].
Studies were not comparable in terms of study designs,
outcomes, and treatments provided, so a meta-analysis could
not be performed.
A summary of included studies was shown in Table 1.
In the study published in 2000, Behneke and coworkers
reported data on 25 implants in 17 patients with signs
and symptoms of peri-implantitis [27]. Access flap surgery
and debridement of the granulation tissue were performed.
Then, air-polishing with bicarbonate powder was applied
for implant surface decontamination. Finally, guided bone
regeneration (GBR) with autogenous bone was used to fill the
bony defect. After three years of follow-up, two failures were
reported. In the other cases an improvement in all clinical
parameters could be observed.
The case series published in 2009 presented the results
of surgical treatment of peri-implantitis in 10 implants in 10
patients [28]. After open flap access to the lesion, sodium
carbonate air-powder was used to decontaminate implant
surface, further debrided with the use of resin curettes.
No bone graft was placed. An improvement in clinical
parameters was reported in all cases. Moreover, the total
amount of TNF-a significantly reduced over time.
The study by Ma´ximo and coworkers, published in 2009,
reported results of surgical treatment of peri-implantitis in 13
implants in 13 subjects. The treatment consisted in surgical
access flap and debridement of implant surface with Teflon
curetted and bicarbonate powder air-abrasive. The authors
reported a significant reduction of a number of bacterial
species detectable in the pocket sulcus [30].
One prospective study on 20 implants with peri-
implantitis in 20 subjects described the clinical outcomes
of surgical treatment with open flap and debridement of
implant surface with Teflon curettes and bicarbonate air-
abrasive powder [29]. At 3 months, all clinical parameters
improved as the presence of inflammatory cytokines reduced.
Recently the retrospective study published by Toma
and colleagues reported data about the treatment of peri-
implantitis through access flap and decontamination with
glycine powder air-polishing without application of any bone
graft [31]. Twenty-two implants in 22 subjects were treated.
Gingival index and probing depth significantly improved in
cases treated with glycine powder.
4. Case Report
A woman, aged 58, nonsmoker, without any systemic dis-
ease (ASA-1 following the classification of the American
Society of Anesthesiologists) that may increase the risk
of peri-implant or periodontal diseases (i.e., diabetes or
immunological impairment) presented with the symptoms of
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Table 1: General characteristics of the included studies.
Authors Year Study type
Number of
subjects/
implants
Type of
defect Treatment Considered parameters Results
Behneke et al.
[27] 2000 Pros. 17/25 NR
Surgical debridement
and air-polishing with
bicarbonate + GBR
with autogenous bone
Marginal bone loss
(MBL); horizontal bone
loss (HBL); vertical bone
loss (VBL)
Two failures; median
MBL: from 6.3mm to
2.1mm (3 y); median
HBL: from 1.8mm to
2.1mm (3 y); median
VBL: from 4.5mm to
0.0mm
de Mendonc¸a
et al. [28] 2009 Case series 10/10 NR
Surgical debridement
+ abrasive sodium
carbonate air-powder
+ resin curettes
BI; PI; PD; CAL; TNF-a
Mean PD reduction:
2.4mm (1 y); mean CAL
reduction: 2.0mm (1 y).
The total amount of
TNF-a significantly
reduced over time
Ma´ximo et al.
[30] 2009 Pros. 13/13 NR
Access flap + Teflon
curettes + air-powder
(sodium carbonate)
PD; CAL
25% with PD ≥ 5mm
after 3 months. Levels of
Treponema denticola,
Tannerella forsythia, and
Parvimonas micra and of
Fusobacterium
nucleatum were lower
after treatment
Duarte et al.
[29] 2009 Pros. 20/20 NR
Access flap + resin
curettes + air-powder
(sodium carbonate)
PD
Mean PD: from 7.5mm
to 4.4mm (3mo).
Significant difference in
inflammatory cytokines
between healthy and
affected implants
Toma et al.
[31] 2014 Retro. 22/22
Air-abrasive device
versus plastic curettes
+ cotton pellets +
saline; no GBR
PD
Significant reduction of
clinical parameters in all
groups; better
improvements for
air-abrasive device
regarding gingival index
and probing depth; no
peri-implantitis
resolution
NR: not reported; PD: probing depth; CAL: clinical attachment level.
peri-implantitis and was referred to the implant-supported
rehabilitation of 2.5 and 2.6. Contextually 2.4 tooth showed
a +2 mobility.
Implants were placed in female, 64 years before the
patient came to the attention of the authors. The subject
referred to pain and swelling in the region of 2.5 and
2.6, associated with sporadic episodes of alithosis. The
clinical assessment allowed finding a probing depth of
14mm mesial/circumferentially to 2.5 with bleeding. After
bidimensional radiographic assessment (with periapical and
panoramic radiograph) a concave bone resorption can be
observed of about 11mm mesial and distal to both implants.
The radiographic images also showed a root-end resection
involving 2.4 tooth with a periapical large lesion encroached
with the peri-implant disease above mentioned.
The implant-supported rehabilitation of 2.5 and 2.6 was
separated in order to achieve a complete clinical diagnosis of
the mobility of both implants. 2.5 did not show any mobility,
while 2.6 showed a mobility of more than 1mm.
The patient was informed about her critical clinical
conditions. One treatment alternative was proposed which
would have implied the removal of both implants and 2.4,
the tridimensional bone reconstruction of the area, and
implant placement after complete healing of the bone grafting
procedure.
The subject, informed about advantages and disadvan-
tages of the proposed alternative, refused, asking for an option
that would have avoided major bone grafting procedure,
maintaining the implants in site if possible.
4.1. Surgical Procedure. After an appropriate planning
through tridimensional imaging fromCBCT scans (Figure 1),
a surgical approach with GBR of 2.5 together with the
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Figure 1: CBCT scans images showing the large concave bone resorption due to peri-implant diseases involving implant-supported
rehabilitation of 2.5 and 2.6.
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extraction of 2.4 and 2.6 (that was considered hopeless due to
massive bone resorption and active infection) was decided. It
was planned, after adequate healing, to place a fixed denture
with mesial cantilever of a single tooth on 2.5.
After complete acceptation of the proposed option, the
patient signed an informed consent form.
The surgical intervention was performed by a clinician
with more than ten years of experience in oral surgery (ST).
After local anesthesia with articaine 4% and epinephrine
1 : 100.000 a full-thickness flap was elevated, extending from
2.3 to the distal portion of 2.6 with a distal vertical release
incision. The tooth 2.4 and the implant in position 2.6 were
extracted because of massive bone resorption and mobility.
The granulation and infected tissue were accurately removed
using surgical curettes. Implant surface was debrided and
decontaminated using an air-powder device using a powder
consisting of erythritol, amorphous silica, and 0.3% chlorhex-
idine (Air-Flow Plus, E.M.S. Electro Medical Systems, Nyon,
Switzerland). The air-powder device was used circumferen-
tially for about 3 minutes at a distance of less than 1 cm from
implant surface.
After the treatment a bone substitute (deproteinized
bovine bone matrix-Bio-Oss, Geistlich Pharma AG, Wol-
husen, Switzerland) mixed with pure platelet-rich plasma
(P-PRP [32]), prepared following the protocol described
in previously published reports [33], was used as grafting
material around the 2.5 implant. Two resorbable collagen
membranes (Bio-Gide, Geistlich Pharma AG, Wolhusen,
Switzerland) were then used. One was placed in order to
isolate the communication with the preserved Schneiderian
membrane due to the extraction of 2.6 implant and the other
to cover the graft (Figure 2).
The flapwas thenmobilized, releasingmuscular insertion
in order to allow a primary closure. The flap was finally
closed with interrupted sutures made of nonresorbable 5/0
ETHILON (Ethicon Inc., Blue Ash, OH, USA) and three
sutures were horizontal mattress (5/0 VICRYL, Ethicon Inc.,
Blue Ash, OH, USA) in a paramarginal position to increase
flap stability during the healing phase. The patient was
advised to avoid mouth rinsing, hard and hot food, hot
drinks, heavy physical work, and tooth brushing during
the day of surgery. Ice packs were provided after surgery.
Moreover the patient was instructed to rinse their mouth
twice daily with chlorhexidine digluconate 0.2% for plaque
control up to 7 days after surgery. The subject was prescribed
nonsteroidal analgesics after the surgical procedure for pain
relief and/or swelling control if needed. Antibiotic therapy
was also prescribed (amoxicillin 1 g, three times a day for five
days). Sutures were removed after 7 days.
4.2. Clinical and Radiographic Evaluation. No complications
occurred in the postsurgical period. The patient reported a
moderate pain on the first two days after surgery with little
swelling and without hematoma. No dehiscence of the flap
occurred.
After six months from surgical intervention a cone-beam
computed tomography served to evaluate the stability of tridi-
mensional bone graft over time (Figure 3). Both clinical and
radiographic examination confirmed a substantial stability of
bone graft that allowed hypothesizing the reosseointegration
of the implant affected by peri-implantitis.
Figure 4 showed periapical and panoramic radiographic
images 12 months after surgical operation confirming the
above mentioned six-month refers.
5. Discussion
The present paper reported the results of a narrative review
about the use of air-powder device in the surgical treatment of
peri-implantitis.The presented case report showed that when
an accurate decontamination of implant surface is performed
the reosseointegration of affected implants could be achieved
even though a longer follow-up ismandatory to confirm these
preliminary observations.
Surgical treatment of peri-implantitis has the objec-
tive of arresting the progression of the disease through
decontamination of implant surface and removal of the
inflammatory tissues [34]. Guided bone regeneration (GBR)
procedures could be used in surgical treatment aiming at
the reconstruction of the bone volume that was lost due to
the infective process. The reosseointegration of the implant
surfaces affected by peri-implantitis has to be considered
the most important objective when a GBR procedure was
performed [34, 35].
Some controlled clinical studies on surgical treatment of
peri-implantitis using GBR reported some clinical benefits
in comparison to control groups, in which GBR was not
performed [36–38].
To obtain a reosseointegration of affected implants and,
in general, the success of surgical procedure a decontamina-
tion/detoxification of the implant surface has to be considered
mandatory [39]. Detoxification techniques could be divided
into chemical and mechanical ones on the basis of the action
of the agents involved [39]. Chemical decontamination could
be performed through the use of saline solutions [40, 41],
citric acid [41–43], chlorhexidine [41], hydrogen peroxide
[43], and other antimicrobials. Mechanical decontamination
implies the action of an agent to physically remove the
microorganisms from implant surface. Laser and photo-
dynamic therapy have been proven to be effective in the
decontamination of implant surface [44, 45]. Another form
of mechanical implant decontamination is implantoplasty
through the removal, with burs, of rough (and potentially
contaminated) portion of implant surface. The aim of the
implantoplasty is to remove the contaminated surfaces and
create the conditions to reduce plaque accumulation [46, 47].
Air-powder abrasives were studied in a number of articles
which showed that the use of amino acid glycine powder can
be effective in removal of bacterial biofilm without altering
the morphological characteristics of implant surface [48, 49].
Further, air-abrasive powder has the advantage of preserv-
ing the surface characteristics of titanium without creating
roughness and alterations that can become a bacterial niche
[50].
Guided bone regeneration can be applied to the surgical
treatment of peri-implantitis with the aim of filling the bone
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(a) (b)
Figure 2: (a) Surgical site after extraction of 2.6 implant and 2.4 tooth contextually to accurately remove granulation and infected tissue. An
intact portion of Schneiderian membrane is visible in the 2.6 implant site. (b) Surgical site showing the GBR technique used. A xenogeneic
scaffold covered by a resorbable membrane was positioned circumferentially around the 2.5 implant generating a “regeneration chamber.”
Figure 3: CBCT scans images after six months from surgical intervention showing a substantial stability of bone graft that allowed
hypothesizing of the reosseointegration of the implant affected by peri-implantitis.
(a) (b)
Figure 4: Comparison between periapical and panoramic radiographs before and after 12 months from surgery.
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cavity created by the inflammatory process [34]. Even though
a number of articles reported good clinical results, implant
surface characteristics and the low contamination appeared
to be key factors to permit bone regeneration [19, 51].
The present paper reported that the use of abrasive
powder devices can be successfully associated with guided
bone regeneration to obtain a significant improvement in
clinical parameters. The case report showed that the use of
powder enriched with erythritol allowed a debridement of
implant surface, without altering its structure, and potentially
removing the bacterial biofilm as was proved in a recently
published in vitro study on the same powder as compared to
glycine [52]. Moreover, guided bone regeneration appeared
to be successful in the short time clinically and radiograph-
ically without presenting any sign of residual infection, even
though it was applied to a large lesion.
In conclusion, surgical treatment of peri-implantitis is
described as a viable option to preserve the affected implant
and to stabilize the clinical parameters, thus arresting the
pathology progression. Guided tissue regeneration could be
achieved only after the disruption of bacterial biofilm from
implant surface which can be achieved using abrasive powder
devices.
Moreover, studies with a wider sample size and a longer
follow-up are needed to validate the procedure described in
the present paper.
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